S Ramani, S Samant, SM Manohar - Future Medicinal Chemistry, 2022 - Taylor & Francis
EGFR is a member of the ERBB family. It plays a significant role in cellular processes such as growth, survival and differentiation via the activation of various signaling pathways. EGFR …
G Bajaj, S Suryawanshi, A Roy… - British journal of clinical …, 2019 - Wiley Online Library
Aims The development of monoclonal antibodies (mAbs) requires an understanding of the interindividual variability (IIV) in pharmacokinetics (PK) at the population level facilitated by …
Therapeutic antibodies are increasingly used to treat various diseases, including neoplasms and chronic inflammatory diseases. Antibodies exhibit complex pharmacokinetic properties …
VL Stauffer, I Turner, P Kemmer, W Kielbasa… - The Journal of …, 2020 - Springer
Background Migraine clinical profile may change with age, making it necessary to verify that migraine treatments are equally safe and effective in older patients. These analyses …
X Li, Z Song, Z Yi, J Qin, D Jiang… - Therapeutic …, 2024 - journals.sagepub.com
Background: Compared with anti-infective drugs, immunosuppressants and other fields, the application of therapeutic drug monitoring (TDM) in oncology is somewhat limited. Objective …
Y Tian, Y Pan, Y Zhang, F Wang, Z Wang - BMEMat, 2024 - Wiley Online Library
Cancer immunotherapy has appeared as a prospective therapeutic modality. Therapeutic antibodies induced in an in vitro expression system act as “targeting missiles” against tumor …
E Chigutsa, AJ Long, JE Wallin - CPT: Pharmacometrics & …, 2017 - Wiley Online Library
We sought to describe the exposure–response relationship of necitumumab efficacy in squamous non‐small cell lung cancer patients and evaluate intrinsic and extrinsic patient …